https://www.selleckchem.com/pr....oducts/folinic-acid.
The factors with the strongest associations were diabetes (OR=3.26; 95%CI 3.07-3.47), dyslipidaemia (OR=2.08; 1.96-2.21), heart failure (OR=2.02; 1.72-2.37), and hypertension (OR=1.78; 1.67-1.9. Among diabetic patients older than 70 years with hypertension and dyslipidaemia, the prevalence of LD-ASA prescription was 33.7%. CONCLUSIONS The prescription of LD-ASA for primary prevention in Spain over the study period was low in the general population, but high in older diabetic patients with additional risk factors. After years of c
Like
Comment
Share
